Literature DB >> 20802011

Detailed analysis of health status of Q fever patients 1 year after the first Dutch outbreak: a case-control study.

G J M Limonard1, J B Peters, M H Nabuurs-Franssen, G Weers-Pothoff, R Besselink, C A R Groot, P N R Dekhuijzen, J H Vercoulen.   

Abstract

BACKGROUND: Q fever is a zoonosis caused by the obligate intracellular bacterium Coxiella burnetii. The two long-term complications, after primary infection, are chronic Q fever in ∼1% of patients, and a chronic fatigue syndrome in 10-20%. However, the existence of a protracted decreased health status after Q fever remains controversial. AIM: To determine the health status of the patients of the Q fever outbreak in The Netherlands in 2007, 1 year after primary infection.
DESIGN: Cross-sectional case-control study.
METHODS: Health status of the patients from the 2007 Dutch Q fever outbreak was compared to age-, sex- and geographically matched and Q fever seronegative controls. Health status of both patients and controls was assessed with the Nijmegen Clinical Screening Instrument (NCSI).
RESULTS: Fifty-four Q fever patients provided 34 years of age- and sex-matched controls from the same neighbourhood. Eleven controls had positive Q fever serology and were excluded. Q fever patients had significantly more problems on the subdomains of symptoms and functional impairment. Overall quality of life was decreased in both patients and controls, 59% vs. 39%, respectively, ns). Severe fatigue levels were present in 52% of patients vs. 26% in controls (P < 0.05).
CONCLUSION: These data support a sustained decrease in many aspects of health status in Q fever patients in The Netherlands, 1 year after primary infection.

Entities:  

Mesh:

Year:  2010        PMID: 20802011     DOI: 10.1093/qjmed/hcq144

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  11 in total

1.  Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages.

Authors:  Joseph G Graham; Laura J MacDonald; S Kauser Hussain; Uma M Sharma; Richard C Kurten; Daniel E Voth
Journal:  Cell Microbiol       Date:  2013-01-14       Impact factor: 3.715

Review 2.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Severely impaired health status of non-notified Q fever patients leads to an underestimation of the true burden of disease.

Authors:  J A F van Loenhout; C C H Wielders; G Morroy; M J M Cox; W van der Hoek; J L A Hautvast; W J Paget; J van der Velden
Journal:  Epidemiol Infect       Date:  2015-01-13       Impact factor: 4.434

4.  Vascular chronic Q fever: quality of life.

Authors:  J C J P Hagenaars; P C Wever; S O A Shamelian; A S Van Petersen; M Hilbink; N H M Renders; G L De Jager-Leclercq; F L Moll; O H J Koning
Journal:  Epidemiol Infect       Date:  2015-01-22       Impact factor: 4.434

5.  The health status of Q-fever patients after long-term follow-up.

Authors:  Gabriëlla Morroy; Jeannette B Peters; Malou van Nieuwenhof; Hans H J Bor; Jeannine L A Hautvast; Wim van der Hoek; Clementine J Wijkmans; Jan H Vercoulen
Journal:  BMC Infect Dis       Date:  2011-04-18       Impact factor: 3.090

6.  Assessing health status and quality of life of Q-fever patients: the Nijmegen Clinical Screening Instrument versus the Short Form 36.

Authors:  Joris A F van Loenhout; W John Paget; Gerwin W Sandker; Jeannine L A Hautvast; Koos van der Velden; Jan H Vercoulen
Journal:  Health Qual Life Outcomes       Date:  2013-07-04       Impact factor: 3.186

Review 7.  Fatigue following Acute Q-Fever: A Systematic Literature Review.

Authors:  Gabriella Morroy; Stephan P Keijmel; Corine E Delsing; Gijs Bleijenberg; Miranda Langendam; Aura Timen; Chantal P Bleeker-Rovers
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

8.  Vasodilator-Stimulated Phosphoprotein Activity Is Required for Coxiella burnetii Growth in Human Macrophages.

Authors:  Punsiri M Colonne; Caylin G Winchell; Joseph G Graham; Frances I Onyilagha; Laura J MacDonald; Heike R Doeppler; Peter Storz; Richard C Kurten; Paul A Beare; Robert A Heinzen; Daniel E Voth
Journal:  PLoS Pathog       Date:  2016-10-06       Impact factor: 6.823

9.  Assessing the long-term health impact of Q-fever in the Netherlands: a prospective cohort study started in 2007 on the largest documented Q-fever outbreak to date.

Authors:  Joris Af van Loenhout; W John Paget; Jan H Vercoulen; Clementine J Wijkmans; Jeannine L A Hautvast; Koos van der Velden
Journal:  BMC Infect Dis       Date:  2012-10-30       Impact factor: 3.090

10.  A cross-sectional study to assess the long-term health status of patients with lower respiratory tract infections, including Q fever.

Authors:  A S G van Dam; J A F van Loenhout; J B Peters; A Rietveld; W J Paget; R P Akkermans; A Olde Loohuis; J L A Hautvast; J van der Velden
Journal:  Epidemiol Infect       Date:  2014-03-14       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.